---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-26-000010"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2026-01-23T23:59:59+00:00"
generated_at: "2026-05-16T08:26:01.141103+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst CCO Kevin Freeman to Depart, Remain as Senior Advisor

## Summary
- Kevin Freeman will cease serving as Chief Commercial Officer on February 1, 2026.
- Company expects to enter a separation agreement and independent contractor agreement for senior advisor role starting February 2, 2026.
- Separation benefits under Executive Severance Plan as summarized in May 2025 proxy statement.
- Transition intended to enable smooth handover of commercial responsibilities.

## SEC filing metadata
- accession: 0001636422-26-000010
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2026-01-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000010/0001636422-26-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000010/hcat-20260120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-26-000010
- JSON: https://secwatch.observer/filing/0001636422-26-000010.json
- Plain text: https://secwatch.observer/filing/0001636422-26-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.